CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells. [electronic resource]
Producer: 20170828Description: 102-112 p. digitalISSN:- 1532-1827
- Antineoplastic Agents, Alkylating -- therapeutic use
- Blotting, Western
- Brain Neoplasms -- drug therapy
- Cell Line, Tumor
- Cell Survival
- Computer Simulation
- Dacarbazine -- analogs & derivatives
- Databases, Factual
- Drug Resistance, Neoplasm -- genetics
- Epithelial-Mesenchymal Transition -- genetics
- Glioblastoma -- drug therapy
- Glycolysis -- genetics
- Humans
- Immunoglobulin J Recombination Signal Sequence-Binding Protein -- genetics
- Isocitrate Dehydrogenase -- genetics
- Mutation
- Neoplasm Invasiveness -- genetics
- Neoplastic Stem Cells -- metabolism
- Prognosis
- RNA, Messenger -- metabolism
- Temozolomide
- Tumor Hypoxia -- genetics
- Zinc Finger E-box-Binding Homeobox 1 -- metabolism
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.